Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms

DEB025 (alisporivir) is a synthetic cyclosporine with inhibitory activity against human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV). It binds to cyclophilin A (CypA) and blocks essential functions of CypA in the viral replication cycles of both viruses. DEB025 inhibits clinical...

Full description

Bibliographic Details
Main Authors: Brigitte Rosenwirth, Jean-Maurice Dumont, Grégoire Vuagniaux, Michael D. Bobardt, Philippe A. Gallay, Roger G. Ptak
Format: Article
Language:English
Published: MDPI AG 2013-03-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/5/3/981
_version_ 1798046442496983040
author Brigitte Rosenwirth
Jean-Maurice Dumont
Grégoire Vuagniaux
Michael D. Bobardt
Philippe A. Gallay
Roger G. Ptak
author_facet Brigitte Rosenwirth
Jean-Maurice Dumont
Grégoire Vuagniaux
Michael D. Bobardt
Philippe A. Gallay
Roger G. Ptak
author_sort Brigitte Rosenwirth
collection DOAJ
description DEB025 (alisporivir) is a synthetic cyclosporine with inhibitory activity against human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV). It binds to cyclophilin A (CypA) and blocks essential functions of CypA in the viral replication cycles of both viruses. DEB025 inhibits clinical HIV-1 isolates in vitro and decreases HIV-1 virus load in the majority of patients. HIV-1 isolates being naturally resistant to DEB025 have been detected in vitro and in nonresponder patients. By sequence analysis of their capsid protein (CA) region, two amino acid polymorphisms that correlated with DEB025 resistance were identified: H87Q and I91N, both located in the CypA-binding loop of the CA protein of HIV-1. The H87Q change was by far more abundant than I91N. Additional polymorphisms in the CypA-binding loop (positions 86, 91 and 96), as well as in the N-terminal loop of CA were detected in resistant isolates and are assumed to contribute to the degree of resistance. These amino acid changes may modulate the conformation of the CypA-binding loop of CA in such a way that binding and/or isomerase function of CypA are no longer necessary for virus replication. The resistant HIV-1 isolates thus are CypA-independent.
first_indexed 2024-04-11T23:37:42Z
format Article
id doaj.art-2482db037e7b462e9f372e0cb101db58
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-04-11T23:37:42Z
publishDate 2013-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-2482db037e7b462e9f372e0cb101db582022-12-22T03:56:53ZengMDPI AGViruses1999-49152013-03-015398199710.3390/v5030981Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid PolymorphismsBrigitte RosenwirthJean-Maurice DumontGrégoire VuagniauxMichael D. BobardtPhilippe A. GallayRoger G. PtakDEB025 (alisporivir) is a synthetic cyclosporine with inhibitory activity against human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV). It binds to cyclophilin A (CypA) and blocks essential functions of CypA in the viral replication cycles of both viruses. DEB025 inhibits clinical HIV-1 isolates in vitro and decreases HIV-1 virus load in the majority of patients. HIV-1 isolates being naturally resistant to DEB025 have been detected in vitro and in nonresponder patients. By sequence analysis of their capsid protein (CA) region, two amino acid polymorphisms that correlated with DEB025 resistance were identified: H87Q and I91N, both located in the CypA-binding loop of the CA protein of HIV-1. The H87Q change was by far more abundant than I91N. Additional polymorphisms in the CypA-binding loop (positions 86, 91 and 96), as well as in the N-terminal loop of CA were detected in resistant isolates and are assumed to contribute to the degree of resistance. These amino acid changes may modulate the conformation of the CypA-binding loop of CA in such a way that binding and/or isomerase function of CypA are no longer necessary for virus replication. The resistant HIV-1 isolates thus are CypA-independent.http://www.mdpi.com/1999-4915/5/3/981DEB025alisporivircyclophilin inhibitorscyclosporinesHIV/retrovirusesHIV capsidnatural resistance
spellingShingle Brigitte Rosenwirth
Jean-Maurice Dumont
Grégoire Vuagniaux
Michael D. Bobardt
Philippe A. Gallay
Roger G. Ptak
Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms
Viruses
DEB025
alisporivir
cyclophilin inhibitors
cyclosporines
HIV/retroviruses
HIV capsid
natural resistance
title Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms
title_full Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms
title_fullStr Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms
title_full_unstemmed Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms
title_short Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms
title_sort correlation of naturally occurring hiv 1 resistance to deb025 with capsid amino acid polymorphisms
topic DEB025
alisporivir
cyclophilin inhibitors
cyclosporines
HIV/retroviruses
HIV capsid
natural resistance
url http://www.mdpi.com/1999-4915/5/3/981
work_keys_str_mv AT brigitterosenwirth correlationofnaturallyoccurringhiv1resistancetodeb025withcapsidaminoacidpolymorphisms
AT jeanmauricedumont correlationofnaturallyoccurringhiv1resistancetodeb025withcapsidaminoacidpolymorphisms
AT gregoirevuagniaux correlationofnaturallyoccurringhiv1resistancetodeb025withcapsidaminoacidpolymorphisms
AT michaeldbobardt correlationofnaturallyoccurringhiv1resistancetodeb025withcapsidaminoacidpolymorphisms
AT philippeagallay correlationofnaturallyoccurringhiv1resistancetodeb025withcapsidaminoacidpolymorphisms
AT rogergptak correlationofnaturallyoccurringhiv1resistancetodeb025withcapsidaminoacidpolymorphisms